NEW YORK (GenomeWeb) – Janney Capital Markets today announced it has upgraded shares of T2 Biosystems to a Buy rating on the results of its first quarter financial update.

Analyst Paul Knight upgraded shares from a previous rating of Neutral and reiterated his target share price of $25 for the company's stock.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.